Holdings
Redmile Group, LLC
As of Jun 30, 2026, Redmile Group, LLC reported 35 positions worth US$1.41B. Largest: Scholar Rock Holding Corporation, Krystal Biotech, Inc. and Stoke Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Scholar Rock Holding Corporation | 4.31M | US$237M | −4.76M | Jun 30, 2026 |
| Krystal Biotech, Inc. | 632K | US$235M | −41,500 | Jun 30, 2026 |
| Stoke Therapeutics, Inc. | 3.95M | US$129M | −218K | Jun 30, 2026 |
| Immunome, Inc. | 4.91M | US$104M | −647K | Jun 30, 2026 |
| Nurix Therapeutics, Inc. | 4.07M | US$98.8M | −3.66M | Jun 30, 2026 |
| Absci Corporation | 6.74M | US$78.1M | −1.51M | Jun 30, 2026 |
| Annexon, Inc. | 11.9M | US$67.8M | −2.68M | Jun 30, 2026 |
| Regenxbio Inc. | 4.37M | US$52.3M | no change | Jun 30, 2026 |
| Shattuck Labs, Inc. | 6.89M | US$47.8M | +1.35M | Jun 30, 2026 |
| Neurogene Inc. | 1.41M | US$44.4M | −47,400 | Jun 30, 2026 |